[{"Assets_0_Q3_USD":"695544000.0","CIK":"1737287","CommonStockSharesConverted_0_Q3_shares":"121895479.0","CommonStockSharesOutstanding_0_Q3_shares":"121895479.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.5","EarningsPerShareBasic_3_Q3_USD":"-1.24","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-87083000.0","NetIncomeLoss_1_Q3_USD":"-50735000.0","NetIncomeLoss_3_Q3_USD":"-123564000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_3_Q3_USD":"-123564000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"619716000.0","Ticker":"ALLO","filed":"20191105","footnote":null,"form":"10-Q","fp":"Q3","fy":"2019.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20190930","qtrs":"0","uom":"USD"}]